Linked Life Data

10933308

Source:http://linkedlifedata.com/resource/pubmed/id/10933308

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2000-11-8
pubmed:abstractText
To investigate whether chronic administration of the long-acting glucagon-like peptide-1 receptor agonist exendin-4 can elicit sustained reductions in food intake and body weight and whether its actions require an intact leptin system.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1071-7323
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
317-23
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats.
pubmed:affiliation
SmithKline Beecham Pharmaceuticals, Department of Vascular Biology, New Frontiers Science Park, Harlow, Essex, United Kingdom. kamal_A_Al-Barazanji@sbphrd.com
pubmed:publicationType
Journal Article